Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign, Inc. (NASDAQ: PAYS) is a fintech and healthcare-focused company whose news flow centers on patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries. News about PAYS often highlights developments in its pharma patient affordability business, plasma donor compensation programs and the performance of its card-based payment platform.
Company press releases frequently cover quarterly financial results, where Paysign reports on total revenues, plasma revenue, pharma patient affordability revenue, gross profit, operating expenses, EBITDA and Adjusted EBITDA. These updates also describe trends in plasma center counts, the number of active pharma patient affordability programs, processed claims and the mix of revenue between plasma, pharma patient affordability and other prepaid and incentive programs.
Another recurring theme in Paysign news is the expansion and refinement of its patient affordability solutions. The company has discussed the growth of pharmaceutical copay programs, the adoption of its Dynamic Business Rules technology to address copay maximizers, and the scale of patient and client savings associated with these programs. Announcements have also described the opening of a patient service support center to increase support capacity for the patient affordability business.
Paysign news items also include participation in investor conferences, board and leadership updates and information about engagement and management platforms for life sciences. For investors, analysts and industry participants, the PAYS news page provides a centralized view of earnings releases, operational milestones, program expansions and corporate governance developments tied to the company’s fintech healthcare ecosystem.
Users interested in PAYS can use this news feed to review historical announcements on plasma and pharma program growth, cardholder and program metrics, litigation and settlement updates, and the company’s commentary on its strategic focus within payment processing and healthcare-related markets.
Paysign, Inc. (NASDAQ: PAYS) will discuss its Q1 2022 earnings on May 11, 2022, at 5:00 p.m. ET. The call will be accessible via a U.S. dial-in or an international number, and a replay will be available after the event. Paysign provides integrated payment processing, digital banking, and prepaid card programs targeting various industries, including healthcare and retail. The company aims to enhance client operations, reduce costs, and improve loyalty through its tailored solutions.
Paysign, Inc. reported a 21% increase in fourth-quarter revenues to $8.8 million and a net income of $105,000. The adjusted EBITDA rose to $1.3 million, reflecting strong growth in plasma (up 20%) and pharma revenues (up 929%). For 2021, total revenues reached $29.5 million, exceeding guidance, with a net loss improved to $2.7 million. Looking ahead, the company anticipates 2022 revenues of $35.25 million to $38.35 million, projecting 20% to 30% growth overall, with significant investment in operations.
Paysign, Inc. (NASDAQ: PAYS) will discuss its fourth-quarter and full-year 2021 earnings on March 22, 2022, at 5:00 p.m. Eastern time. The earnings call will provide insights into the company's performance in prepaid card programs, digital banking services, and integrated payment processing. Interested parties can join via dial-in or webcast. A replay of the call will be available until June 22, 2022. Paysign specializes in customized payment solutions across various sectors, aiming to streamline operations and enhance customer loyalty.
Paysign, Inc. (NASDAQ: PAYS) reported third-quarter 2021 revenues of $7.8 million, showing a year-over-year increase of $7.9 million. Plasma revenue also rose to $7.0 million, marking a 35.6% increase. The net loss narrowed to $0.3 million, translating to a diluted EPS of ($0.01). Adjusted EBITDA stood at $1.0 million, with a diluted adjusted EBITDA per share of $0.02. Transaction volumes surged, with purchase dollar volume rising 33.9% year-over-year, reflecting improved operational metrics despite ongoing pandemic challenges.
Paysign, Inc. (NASDAQ: PAYS), a leader in prepaid card programs and digital banking, will announce its third-quarter 2021 earnings on November 9, 2021, at 5:00 p.m. Eastern time. The earnings call will be accessible via dial-in and webcast. Interested participants must register by November 5, 2021, to submit questions. Paysign focuses on providing integrated payment solutions across various sectors, enhancing operational efficiencies and driving revenue growth.
Paysign, Inc. (NASDAQ: PAYS) announced its Q2 2021 financial results, showing a 3.2% revenue increase to $6.4 million, driven by a 30.1% rise in plasma revenue. The company reported a net loss of $0.9 million and raised its full-year revenue forecast to $29.0 million - $32.0 million, reflecting a growth of 20% to 32%. Adjusted EBITDA guidance was improved to $0.75 million - $1.90 million. The company anticipates continued improvements as pandemic-related government supports wane, though it remains cautious about COVID-19's ongoing impact.
Paysign, Inc. (NASDAQ: PAYS), announced significant leadership appointments to enhance its technology and product offerings. Brad Cunningham joins as chief technology officer, bringing 17 years of experience in fintech, particularly in modernizing banking systems. Alan Geiger and Richard Graub also join as directors of relationship management and product management, respectively, aiming to strengthen connectivity in the plasma collection sector and advance product strategies.
Paysign, Inc. (NASDAQ: PAYS) will host a conference call on August 10, 2021, at 5:00 p.m. ET to discuss its second-quarter 2021 earnings. Participants can join via U.S. dial-in at 877.407.2988 or international dial-in at 201.389.0923, with a webcast available.
A replay will be accessible until November 10, 2021. Founded in 2001, Paysign provides innovative prepaid card programs and digital banking solutions tailored for various sectors including healthcare and retail. For more details, visit paysign.com.
Summary not available.
Paysign, Inc. (NASDAQ: PAYS) reported its first-quarter 2021 financial results, showing a 40.6% revenue decline to $6.3 million compared to Q1 2020. Plasma revenue decreased 26.7% due to lower donations exacerbated by pandemic-related factors. Despite adding three new plasma centers, average revenue per center dropped 38.8%. For 2021, Paysign anticipates total revenue between $29.0 million and $32.0 million, with adjusted EBITDA forecasted at $0.35 million to $1.90 million. The company maintains a healthy balance sheet with $6.6 million in cash and zero debt.